Le Lézard
Classified in: Health
Subject: STP

Physician General Discusses Wolf Administration's $26.5 Million Federal Grant to Combat Heroin and Opioid Crisis for Pennsylvania Medical Society Event


HARRISBURG, Pa., May 3, 2017 /PRNewswire-USNewswire/ -- Physician General Dr. Rachel Levine today explained how the Wolf Administration plans to use the $26.5 million 21st Century Cures Grant in its ongoing effort to curb the opioid epidemic with members of the Pennsylvania Medical Society (PAMED).

"The funding that Governor Wolf was able to secure under the 21st Century Cures Grant is essential to support our effort to help Pennsylvanians suffering from addiction," said Dr. Levine. "Ensuring access to treatment allows us to offer hope to those struggling with the disease of addiction. I thank PAMED for allowing me to join them and discuss this incredibly important topic."

The U.S. Department of Health and Human Services awarded the grant, which totals $1 billion nationwide over the next two years. The grant will help combat the heroin and opioid epidemic in all 50 states. Pennsylvania received the fourth-largest grant award, behind California, Texas and Florida.

States can use the federal grants to increase access to and capacity for treatment, improve prescription drug monitoring programs, implement prevention activities, and train health care providers on overdose prevention and recognizing potential cases of substance abuse.

The Wolf Administration holds the fight against heroin and prescription opioids as a top priority.  To continue the battle against the opioid epidemic in Pennsylvania, Governor Wolf included the following proposals in his 2017-18 budget:

 Some of the administration's other initiatives to fight the opioid epidemic include:

If you or someone you know is suffering from the disease of addiction, call 1-800-662-HELP or visit www.pa.gov/opioids for treatment options. For more information on the fight against opioid abuse in Pennsylvania, visit the Department of Health website at www.health.pa.gov or follow us on Facebook and Twitter.

MEDIA CONTACT: April Hutcheson, 717-787-1783 or [email protected]

 

SOURCE Pennsylvania Department of Health


These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

18 mai 2024
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: